Skip to main content

Clinical Trials

The Canadian Cancer Trials Group (CCTG) supports national and international multicentre phase I-III cancer clinical research trials aimed at improving the survival and quality of life of cancer patients across all cancer types. The scientific agenda for the group is developed by clinical researchers across Canada and beyond, includes trials of new cancer agents, novel radiation and surgical techniques, as well as interventions to improve patient quality of life.

If you are a CCTG member and need to access the full trials pages please click here.

The links below will take you to pages that list all the current CCTG trials with a brief description. If you are interested in volunteering for a trial we suggest that you discuss the opportunity with your care team.

If you are a patient or caregiver and are looking for other information about clinical trials a complete listing of clinical trials being conducted in Canada, including the locations where they are being conducted, can be found here: Canadian Cancer Trials.  And if you are interested in learning about participating in a clinical trial more information can be found here: www.itstartswithme.ca

 

How can I participate in a clinical trial

 

How can I participate in a clinical trial

CCTG SR.8 HARMONY sarcoma trial awarded CIHR funding

CCTG SR8 HARMONY sarcoma trial awarded CIHR funding

The CCTG SR.8 (HARMONY) clinical trial has been awarded almost 1.5 million through the CIHR spring Project Grant Program. A phase III study that addresses a significant unmet need in the treatment of high-risk soft-tissue sarcoma (STS).

More >>
 
The BR38 trial testing targeted radiotherapy added to immunotherapy to improve outcomes for lung cancer patients.

The BR38 trial is testing targeted radiotherapy added to immunotherapy to improve outcomes for lung cancer patients

The recently opened BR38 clinical trial is exploring whether adding stereotactic body radiotherapy (SBRT) to the current treatment of immunotherapy (with or without chemotherapy) can improve outcomes for patients with metastatic non-small cell lung cancer (NSCLC) and limited disease progression (oligoprogression).

More >>
 
MA.40 FINER clinical trial

Clinical Trial Shows Promise in Slowing Advanced Breast Cancer Progression

In an important clinical trial research finding for advanced breast cancer treatment, the Canadian Cancer Trials Group (CCTG) has announced the results from the MA.40 clinical trial. These study results highlight the importance of targeting the AKT pathway to slow tumour progression in patients with advanced estrogen receptor-positive (ER+)/HER2-negative breast cancer.

More >>
 
CCS Breakthrough Grant awarded for The Canadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT):

CCS Breakthrough Grant awarded for The Canadian Network for Psychedelic-Assisted Cancer Therapy

A new national initiative as been funded by the Canadian Cancer Society, through their Breakthrough Team Grant competition.

More >>